Skip to main content

Table 1 Subject characteristics

From: Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma

Patient characteristics n (%)
Age, mean ± SD (year) 50.9 ± 11.5
Male, n (%) 238 (85.0%)
Diabetes, n (%) 22 (7.9%)
Hypertension, n (%) 53 (18.9%)
 Background liver disease
  HB 176
  HC 8
  HB and HC 2
  Non-B non-C 94
ASA grading, mean + SD 2.3 ± 0.6
Hemoglobin, mean ± SD (g/dL) 130.7 ± 19.7
White blood cell count, mean ± SD (109/L) 5.5 ± 2.5
Platelet count, mean ± SD (109/L) 135.8 ± 71.0
Total bilirubin, mean ± SD (μmol/L) 24.4 ± 45.7
ALT, mean ± SD (U/L) 54.2 ± 57.1
AST, mean ± SD (U/L) 56.8 ± 63.2
INR, mean ± SD 1.08 ± 0.1
Albumin, mean ± SD (g/L) 39.1 ± 5.5
GP73, mean ± SD (ng/mL) 111.8 ± 153.3
Child–Pugh score, mean ± SD 5.6 ± 1.0
Child–Pugh grade (A/B/C) 262/18/0
Size of largest tumor, mean ± SD (cm) 6.2 ± 3.6
Solitary tumor, n (%) 246 (87.9%)
Blood loss, mean ± SD (min) 805.8 ± 961.8
Intermittent hilar clamping, mean ± SD (min) 14.3 ± 15.2
Operation time, mean ± SD (min) 233.5 ± 200.2
Intraoperative procedures
 Minor hepatectomy 199
 Major hepatectomy 81
Clavien–Dindo classification
 Grade 1 35
 Grade 2 81
 Grade 3a/3b 19/1
 Grade 4a/4b 5/0
 Grade 5 4
  1. AST aspartate aminotransferase, ALT alanine aminotransferase, ASA American Society of Anesthesiology, HBV hepatitis B virus, HCV hepatitis C virus